MDA-9 and uses thereof
US6866993B1 · kind B1 · utility
9Cited by
1References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 21, 2000 |
| Grant date | Mar 15, 2005 |
| Priority date | — |
| Expiry date | Mar 21, 2020 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/44
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Increased expression of MDA-9 is associated with drug resistance of certain cells (e.g., cancer cells). The invention provides methods for identifying drug resistant cells by measuring the expression or activity of MDA-9, methods for identifying modulators of drug resistance, and methods for modulating drug resistance by modulating the expression or activity of MDA-9.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.